Artis funds Excision to test whether CRISPR can cure HIV – FierceBiotech
FierceBiotech |
Artis funds Excision to test whether CRISPR can cure HIV
FierceBiotech Excision sees an HIV CRISPR Cas9/gRNA multiplex biologic based on Khalili's work—EBT101—as its best shot of meeting this lofty goal. The plan is to wrap up IND-enabling studies of the candidate in the months to come and get it into the clinic around … |
